| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.4M | -53.8% |
| SG&A Expense | $16.7M | +5.1% |
| Operating Income | -$42.1M | +31.1% |
| Pre-tax Income | -$41.5M | +30.4% |
| Net Income | -$41.5M | +30.4% |
| EPS (Basic) | -$0.67 | +51.8% |
| EPS (Diluted) | -$0.67 | +51.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.3M | +84.0% |
| Short-term Investments | $44.4M | -15.0% |
| Current Assets | $73.9M | +1.2% |
| Total Assets | $75.5M | +0.4% |
| Current Liabilities | $8.1M | +12.5% |
| Long-term Debt | $53.4M | +7.2% |
| Total Liabilities | $62.4M | +6.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.8M | +37.9% |
| Capital Expenditures | $33K | -70.5% |
| Investing Cash Flow | $8.3M | +74.2% |
| Financing Cash Flow | $32.1M | -32.8% |
| Free Cash Flow | -$28.9M | +37.9% |
| Stockholders' Equity |
| $13.1M |
| -21.6% |